|
Volumn 22, Issue 7, 2004, Pages 1341-1342
|
Impact on outcome of delay in starting radiotherapy [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BREAST CANCER;
CANCER CONTROL;
CANCER PATIENT;
CANCER RECURRENCE;
CHEMOTHERAPY;
FOLLOW UP;
HUMAN;
LETTER;
PRIORITY JOURNAL;
RADIATION DOSE;
TREATMENT OUTCOME;
BREAST TUMOR;
CLINICAL TRIAL;
FEMALE;
METASTASIS;
NOTE;
PATHOLOGY;
RADIATION DOSE FRACTIONATION;
TIME;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DOSE FRACTIONATION;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 2142696592
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2004.99.056 Document Type: Letter |
Times cited : (13)
|
References (7)
|